Correlations between the MV-PGC and MV subsets
| . | r (Spearman) . | P . |
|---|---|---|
| AnnV+ MVs | 0.43 | .01 |
| Gran-MVs (annV/CD15) | 0.34 | .05 |
| P-MVs (annV/CD41) | 0.16 | .5 |
| Ery-MVs (annV/CD235a) | 0.08 | .7 |
| E-MVs (annV/CD146) | 0.03 | .9 |
| . | r (Spearman) . | P . |
|---|---|---|
| AnnV+ MVs | 0.43 | .01 |
| Gran-MVs (annV/CD15) | 0.34 | .05 |
| P-MVs (annV/CD41) | 0.16 | .5 |
| Ery-MVs (annV/CD235a) | 0.08 | .7 |
| E-MVs (annV/CD146) | 0.03 | .9 |
P ≤ .05 was considered a significant nonparametric correlation (Spearman’s correlation).
annV+ MVs, annexin V+ microvesicles; E-MVs, endothelial-derived MVs; Ery-MVs, erythrocyte-derived MVs; Gran-MVs, granulocyte-derived MVs; P-MVs, platelet-derived MVs.